| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ... Critical care medicine 49 (11), e1063-e1143, 2021 | 4016 | 2021 |
| Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the … AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ... Clinical infectious diseases 63 (5), e61-e111, 2016 | 3867 | 2016 |
| DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Clinical infectious diseases 58 (8), 1072-1083, 2014 | 1070 | 2014 |
| Pharmacokinetic issues for antibiotics in the critically ill patient JA Roberts, J Lipman Critical care medicine 37 (3), 840-851, 2009 | 988 | 2009 |
| Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... The Lancet infectious diseases 14 (6), 498-509, 2014 | 904 | 2014 |
| Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020 | 608 | 2020 |
| The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients M Ulldemolins, JA Roberts, J Rello, DL Paterson, J Lipman Clinical pharmacokinetics 50, 99-110, 2011 | 506 | 2011 |
| Subtherapeutic initial β-lactam concentrations in select critically ill patients AA Udy, JM Varghese, M Altukroni, S Briscoe, BC McWhinney, ... Chest 142 (1), 30-39, 2012 | 466 | 2012 |
| Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, C Gomersall, ... Clinical infectious diseases 56 (2), 236-244, 2013 | 429 | 2013 |
| Obesity in the critically ill: a narrative review M Schetz, A De Jong, AM Deane, W Druml, P Hemelaar, P Pelosi, ... Intensive care medicine 45, 757-769, 2019 | 424 | 2019 |
| Augmented renal clearance: implications for antibacterial dosing in the critically ill AA Udy, JA Roberts, RJ Boots, DL Paterson, J Lipman Clinical pharmacokinetics 49, 1-16, 2010 | 415 | 2010 |
| Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials JA Roberts, MH Abdul-Aziz, JS Davis, JM Dulhunty, MO Cotta, J Myburgh, ... American journal of respiratory and critical care medicine 194 (6), 681-691, 2016 | 412 | 2016 |
| Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept JA Roberts, M Ulldemolins, MS Roberts, B McWhinney, J Ungerer, ... International journal of antimicrobial agents 36 (4), 332-339, 2010 | 412 | 2010 |
| Antibiotic resistance—what’s dosing got to do with it? JA Roberts, P Kruger, DL Paterson, J Lipman Critical care medicine 36 (8), 2433-2440, 2008 | 410 | 2008 |
| Therapeutic drug monitoring of antimicrobials JA Roberts, R Norris, DL Paterson, JH Martin British journal of clinical pharmacology 73 (1), 27-36, 2012 | 381 | 2012 |
| Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and … JA Roberts, CMJ Kirkpatrick, MS Roberts, TA Robertson, AJ Dalley, ... Journal of antimicrobial chemotherapy 64 (1), 142-150, 2009 | 381 | 2009 |
| Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis JA Roberts, J Lipman Clinical pharmacokinetics 45, 755-773, 2006 | 379 | 2006 |
| Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation K Shekar, JF Fraser, MT Smith, JA Roberts Journal of critical care 27 (6), 741. e9-741. e18, 2012 | 332 | 2012 |
| The clinical relevance of plasma protein binding changes JA Roberts, F Pea, J Lipman Clinical pharmacokinetics 52, 1-8, 2013 | 328 | 2013 |
| Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in … MH Abdul-Aziz, H Sulaiman, MB Mat-Nor, V Rai, KK Wong, MS Hasan, ... Intensive care medicine 42, 1535-1545, 2016 | 313 | 2016 |
